Genetic screening for prostate cancer can help identify inherited risks early, guide treatment decisions, and protect your family’s health. At Fred Hutch Cancer Center, we offer expert genetic ...

A new study published in JCO Precision Oncology has identified a relatively simple method to predict the cancer patients most likely to develop severe toxicities from chemotherapy. If doctors can ...

For 10% of colorectal cancer patients, hereditary factors play a role, with higher percentages among younger patients.

Integrating new AI screening tools for BRCA and HRD breast-cancer mutations into routine care could lead to earlier detection, more precise treatment, and lives saved. If they are aware of the threat, ...

A groundbreaking study shows that breast cancer screening works better when it’s personalized. Instead of annual mammograms ...

Targeting men in the top 10% of genetic risk helped detect high-grade prostate cancer that conventional screening would miss, paving the way for more personalized and effective early detection ...

It can be argued that the devastation of a cancer diagnosis is rooted as much in the prospect of treatment as it is in the prospect of death. In particular, drugs used to treat cancer can cause severe ...

Shoshana Ungerleider is many things: an internal medicine physician, a science journalist, a San Francisco resident, a host and producer of TED Health, and founder of End Well, a nonprofit ...

Myriad Genetics, Inc. announced in a press release that a study published in JCO Precision Oncology indicates their RiskScore® tool enhances breast cancer screening by aligning clinician ...

Diagnostics and imaging innovation is advancing rapidly, with new screening technologies expanding what's possible in early cancer detection. Providers need clear guidance on how to incorporate ...